By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084


SEARCH JOBS


Industry
Biotechnology






Company News
Advaxis, Inc. To Receive $1.7M Through New Jersey Technology Business Tax (NOL) Program 11/20/2014 2:12:51 PM
Advaxis, Inc. Submits Investigational New Drug Application For Phase 1/2 Study Of ADXS-HPV And Medimmune's MEDI4736 For The Treatment Of HPV-Associated Cervical And Head & Neck Cancer 11/12/2014 7:34:50 AM
Advaxis, Inc. Submits Investigational New Drug Application For ADXS31-142 (ADXS-PSA) For The Treatment Of Metastatic Castration Resistant Prostate Cancer 11/5/2014 8:27:17 AM
Advaxis, Inc. To Present Survival Data Of Lm-LLO Cancer Immunotherapies In Recurrent Cervical Cancer And Canine Osteosarcoma At The Society For Immunotherapy Of Cancer 29th Annual Meeting 11/4/2014 12:25:58 PM
Advaxis, Inc.'s ADXS-Cher2 Immunotherapy Demonstrates T-Cell Immune Response In Data Analysis From Canine Osteosarcoma Study 10/30/2014 10:22:33 AM
Advaxis, Inc. Appoints David J. Mauro, M.D., Ph.D., As Chief Medical Officer 10/20/2014 6:31:41 AM
Advaxis, Inc. Provides Clinical Update For Phase 1/2 Trial Of ADXS-HPV Immunotherapy Product Candidate In Anal Cancer 10/15/2014 7:45:37 AM
Advaxis, Inc.'s Lm-LLO Immunotherapy Data To Be Presented In Three Posters At The Society For Immunotherapy Of Cancer 29th Annual Meeting 10/14/2014 1:38:18 PM
Advaxis, Inc. Appoints World Renowned Oncologist And Research Scientist, Dr. Samir N. Khleif, To Its Board Of Directors 10/8/2014 7:17:13 AM
Advaxis, Inc.'s Chief Scientific Officer, Dr. Robert Petit, Leads Panel Discussion On Combination Immunotherapies 10/1/2014 10:12:38 AM
12345678910...
//-->